Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 12 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

12 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 17, 2025 PLRX S 10b5-1 18,478 $11.20 $206,954 194,574 Direct -8.67% Disposed -90.8% (price as of 2026-10-02)
July 10, 2024 PLRX S 10b5-1 12,319 $11.56 $142,408 213,052 Direct -5.47% Disposed -91.0% (price as of 2026-10-02)
Jan. 17, 2024 PLRX S 10b5-1 10,295 $17.23 $177,383 156,920 Direct -6.16% Disposed -94.0% (price as of 2026-10-02)
July 17, 2023 PLRX S 10b5-1 22,321 $18.01 $402,001 167,215 Direct -11.78% Disposed -94.3% (price as of 2026-10-02)
March 30, 2023 PLRX S 10b5-1 11,245 $26.52 $298,217 145,786 Direct -7.16% Disposed -96.1% (price as of 2026-10-02)
Jan. 23, 2023 PLRX S 10b5-1 67,500 $34.48 $2,327,400 76,926 Direct -46.74% Disposed -97.0% (price as of 2026-10-02)
Dec. 20, 2022 PLRX S 10,887 $19.10 $207,942 144,426 Direct -7.01% Disposed -94.6% (price as of 2026-10-02)
Oct. 25, 2022 PLRX S 10b5-1 5,000 $25.05 $125,250 133,437 Direct -3.61% Disposed -95.9% (price as of 2026-10-02)
July 11, 2022 PLRX S 10b5-1 3,000 $20.00 $60,000 138,436 Direct -2.12% Disposed -94.8% (price as of 2026-10-02)
June 18, 2021 PLRX S 10b5-1 22 $30.23 $665 137,080 Direct -0.02% Disposed -96.6% (price as of 2026-10-02)
June 18, 2021 PLRX S 10b5-1 3,728 $29.43 $109,715 137,102 Direct -2.65% Disposed -96.5% (price as of 2026-10-02)
June 18, 2021 PLRX S 10b5-1 8,750 $28.62 $250,425 140,830 Direct -5.85% Disposed -96.4% (price as of 2026-10-02)
March 18, 2021 PLRX S 10b5-1 1,135 $39.78 $45,150 149,580 Direct -0.75% Disposed -97.4% (price as of 2026-10-02)
March 18, 2021 PLRX S 10b5-1 11,365 $39.38 $447,554 150,715 Direct -7.01% Disposed -97.4% (price as of 2026-10-02)
Dec. 18, 2020 PLRX S 10b5-1 5,712 $26.98 $154,110 162,080 Direct -3.40% Disposed -96.2% (price as of 2026-10-02)
Dec. 18, 2020 PLRX S 10b5-1 6,788 $26.17 $177,642 167,792 Direct -3.89% Disposed -96.0% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 23, 2025 PLRX Stock Option (Right to Buy) Common Stock (91,300) $11.14 Jan. 23, 2035 91,300 Acquired
Jan. 23, 2024 PLRX Stock Option (Right to Buy) Common Stock (85,800) $17.44 Jan. 23, 2034 85,800 Acquired
Jan. 25, 2023 PLRX Stock Option (right to buy) Common Stock (80,000) $34.65 Jan. 24, 2033 80,000 Acquired
Jan. 26, 2022 PLRX Stock Option (right to buy) Common Stock (140,000) $11.86 Jan. 25, 2032 140,000 Acquired
Jan. 23, 2021 PLRX Stock Option (right to buy) Common Stock (73,250) $26.50 Jan. 22, 2031 73,250 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
June 2, 2020 PLRX Common Stock 174,580 Direct
June 2, 2020 PLRX Stock Option (right to buy)→ Common Stock (62,937) 62,937 Direct
June 2, 2020 PLRX Stock Option (right to buy)→ Common Stock (57,646) 57,646 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PLRX

M.D.Former Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $571,861 $215,617 · · · · $666,486 $2,724,860
2024 $520,312 · · · $228,937 · $13,089 $2,615,618
2023 $500,300 · · · $220,131 · $13,980 $4,687,061

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.